BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35297586)

  • 1. Preoperative Helical Dynamic Enhanced Multidetector Row Computed Tomography: Can It Be a Prognostic Indicator in Early-Stage Non-small Cell Lung Cancer?
    Moon JW; Yi CA; Lee KS; Woo SY; Kwon OJ; Yang E; Kim JH; Han J
    J Comput Assist Tomogr; 2022 Mar-Apr 01; 46(2):308-314. PubMed ID: 35297586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
    Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer.
    Nam JG; Hong H; Choi SH; Park CM; Goo JM; Kim YT; Kim H
    Radiology; 2022 Jun; 303(3):632-643. PubMed ID: 35258373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY; Cho A; Yu WS; Lee CY; Lee JG; Kim DJ; Chung KY
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
    Aragaki M; Kato T; Fujiwara-Kuroda A; Hida Y; Kaga K; Wakasa S
    J Cardiothorac Surg; 2020 Aug; 15(1):229. PubMed ID: 32859238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
    Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
    Chou HP; Lin KH; Huang HK; Lin LF; Chen YY; Wu TH; Lee SC; Chang H; Huang TW
    Eur Radiol; 2021 Oct; 31(10):8021-8029. PubMed ID: 33763721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
    Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
    Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
    Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer.
    Wainer Z; Daniels MG; Callahan J; Binns D; Hicks RJ; Antippa P; Russell PA; Alam NZ; Conron M; Solomon B; Wright GM
    J Nucl Med; 2012 Nov; 53(11):1676-85. PubMed ID: 22984219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I-III colon cancer.
    Wang Z; Ye Y; Hu Y; Han S; Sun L; Xu D; Ding K
    Eur Radiol; 2019 Mar; 29(3):1114-1123. PubMed ID: 30255251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
    van den Berg LL; Klinkenberg TJ; Groen HJM; Widder J
    J Thorac Oncol; 2015 May; 10(5):826-831. PubMed ID: 25629639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
    Nair VS; Barnett PG; Ananth L; Gould MK;
    Chest; 2010 May; 137(5):1150-6. PubMed ID: 20038738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
    Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
    Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.